Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy

Clinical trial NCT03911219 · COMPLETED

Trial details

NCT number: NCT03911219
Sponsor: iOMEDICO AG
Status: COMPLETED
Study type: OBSERVATIONAL

Stage IV Non-small Cell Lung Cancer Extensive-stage Small Cell Lung Cancer Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC

Start date: 2019-07-10
Primary completion: 2021-07-01
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.